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During embryonic development, immature neurons in the olfactory epithelium (OE) extend
axons through the nasal mesenchyme, to contact projection neurons in the olfactory bulb.
Axon navigation is accompanied by migration of the GnRH+ neurons, which enter the ante-
rior forebrain and home in the septo-hypothalamic area.This process can be interrupted at
various points and lead to the onset of the Kallmann syndrome (KS), a disorder characterized
by anosmia and central hypogonadotropic hypogonadism. Several genes has been identi-
fied in human and mice that cause KS or a KS-like phenotype. In mice a set of transcription
factors appears to be required for olfactory connectivity and GnRH neuron migration; thus
we explored the transcriptional network underlying this developmental process by pro-
filing the OE and the adjacent mesenchyme at three embryonic ages. We also profiled
the OE from embryos null for Dlx5, a homeogene that causes a KS-like phenotype when
deleted.We identified 20 interesting genes belonging to the following categories: (1) trans-
membrane adhesion/receptor, (2) axon-glia interaction, (3) scaffold/adapter for signaling, (4)
synaptic proteins. We tested some of them in zebrafish embryos: the depletion of five (of
six) Dlx5 targets affected axonal extension and targeting, while three (of three) affected
GnRH neuron position and neurite organization. Thus, we confirmed the importance of
cell–cell and cell-matrix interactions and identified new molecules needed for olfactory
connection and GnRH neuron migration. Using available and newly generated data, we
predicted/prioritized putative KS-disease genes, by building conserved co-expression net-
works with all known disease genes in human and mouse. The results show the overall
validity of approaches based on high-throughput data and predictive bioinformatics to iden-
tify genes potentially relevant for the molecular pathogenesis of KS. A number of candidate
will be discussed, that should be tested in future mutation screens.
Keywords: olfactory development, GnRH neuron, Kallmann syndrome, extracellular matrix, transcription profiling,
disease gene prediction
INTRODUCTION
Central Hypogonadic Hypogonadism (CHH), is a heterogeneous
genetic disorders characterized by absent or incomplete puberty,
due to low circulating gonadotropins and sex steroids. Its mode of
inheritance can be X-linked, autosomal dominant, or autosomal
recessive, although unrelated sporadic cases occur more frequently
(1). The disease is often associated with anosmia/hyposmia, in this
case it is known as Kallmann Syndrome [KS, on-line Mendelian
inheritance in man (OMIM) 308700], or with a normal sense of
smell (normosmic CHH, or nCHH). These conditions are variably
associated with non-reproductive phenotypes such as unilateral
renal agenesis, skeletal abnormalities, midline malformations, or
hearing loss. Neurological symptoms (including synkinesia of the
hands, sensorineural deafness, eye-movement abnormalities, cere-
bellar ataxia, and gaze-evoked horizontal nystagmus) may also
occur depending on the specific mode of inheritance (2).
Mutations affecting a large number of unrelated genes
have been linked to the onset of KS/nCHH, currently includ-
ing Anosmin1 (KAL1), Fibroblast Growth Factor Receptor-1
(FGFR1), Fibroblast Growth Factor 8 (FGF8), GnRH receptor
(GNRH-R), Nasal Embryonic LHRH Factor (NELF), Kisspeptin
(KISS1); Kisspeptin Receptor (KISS-R)/G-protein-Coupled Recep-
tor 54 (GPR54), Prokineticin-2 (PROK-2), Prokineticin Receptor-
2 (PROKR2), Chromodomain Helicase DNA-binding Protein 7
(CHD7), Neurokinin-B (TAC3), Neurokinin-B Receptor (TAC3R),
Heparan Sulfate 6-O-SulphoTransferase 1 (HS6ST1), SOX10,
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Semaphorin-3A (SEMA3A), and five novel genes, members of the
“FGF8-synexpressome” (1–8). In addition, several mouse models
of targeted gene disruption have been shown to exhibit a KS-like
phenotype (6, 9–18).
Despite the number of genes mutated in KS/nCHH, the major-
ity of patients (>60%) do not harbor mutations in known disease
genes, thus it is expected that many additional disease loci remain
to be identified. In addition, the mutations found in KS/nCHH
patients, once thought to act alone, are now recognized as cooper-
ating mutations, and in fact in some cases a bi-genic or oligo-genic
origin of these disease has been reported, with specific geno-
type/phenotype correlations (19–22). These findings open ques-
tions on the actual prevalence of single and combined mutations,
the functional cooperation between them, and the possibility to
use these information for accurate prognostic evaluations.
Kallmann syndrome is righteously considered a developmental
disease. During embryonic development the GnRH neurons orig-
inate in the primitive olfactory area, migrate along the extending
axons from the olfactory epithelium (OE) and the vomero-nasal
organ (VNO), reach the anterior-basal forebrain and home in
the septo-hypothalamic region of the adult brain (23–28). The
association of the olfactory axons with the immature GnRH neu-
rons, hence their ability to migrate and reach the hypothalamus,
is an ancient and highly conserved developmental process, justi-
fied by the fact that it is essential for puberty and reproduction,
in addition to neuro-modulatory functions (27, 29, 30). Not sur-
prisingly this process is governed by a large set of molecular cues.
Several studies have identified specific signaling molecules and
their cognate receptors, as well as adhesion molecules, axon-glia
and axon-matrix molecules play a role in guiding the axons to
the correct position and consent the penetration of the basement
membrane and the brain parenchyma (31–40). For instance, the
semaphorin co-receptor Nrp1 is expressed by extending axon and
GnRH neurons, and mediates the guiding functions of Sema3a,
expressed in the nasal mesenchyme (10, 11). FGF8 has been shown
to act as survival factor for olfactory and migrating GnRH neu-
rons, which express its receptor FGFR1 (41–43), and both genes
are mutated in a subset of KS/nCHH patients. To further com-
plicate the picture, a cell population on the surface of the OB
interacts with incoming axons, GnRH neurons and the CNS, and
provide key signals for basement membrane fenestration, hence
axon connectivity (44).
Due to the close relationship of olfactory axon elonga-
tion/connectivity and GnRH migration that occurs during embry-
onic development, the GnRH neuronal migration is strictly depen-
dent on the integrity and connectivity of the olfactory pathway
(30). A premature termination or mislocalization of olfactory
axons results in impaired odor perception and GnRH homing.
Thus, defects in olfactory development and/or GnRH neuron
migration are considered the main primary cause of KS. The
genetic findings summarized above have revealed much about
the abnormalities that can befall both the development of the
olfactory sensory system and GnRH neuron ontogenesis, includ-
ing their differentiation, migration, maturation, circuit formation,
and senescence.
Experimentally, animal models with altered olfactory and
GnRH development are becoming available, including mouse,
Zebrafish, and Medaka. The zebrafish embryo is ideal for develop-
mental genetic studies, and the depletion of anosmin-1a leads to
altered olfactory development and a KS-like phenotype (45, 46).
In mice, several mutant strains display a phenotype that closely
resemble KS/nCHH, including mouse mutant for Dlx5 (14, 16,
47), Emx2 (18), Klf7 (13), FezF1 (17, 48), Six1 (12), Prok2 and its
receptor Prokr2 (6, 15), Lhx2 (9), Ebf2 (49), Nrp1 and Sema3a (10,
11). Notably, 7 of these (Dlx5, Emx2, Klf7, Six1, FezF1, Ebf2, and
Lhx2) code for unrelated transcription factors, thus it can be pos-
tulated the existence of transcription regulatory networks, yet to
be uncovered, that sustain olfactory development and connectivity,
consent migration of the GnRH neurons and may contribute to the
onset of KS/nCHH when altered. Furthermore, it is increasingly
recognized that biological processes are governed and regulated
by regulatory modules and networks of molecular interaction,
not limited to protein-coding genes, rather then simplistically by
individual genes.
To advance in our knowledge on the molecular regulation of
axon extension/connectivity and GnRH neuron migration, in the
present study we adopted a strategy based on the generation of
transcriptome-wide profile data, combined with bioinformatic
analyses and meta-analyses. In addition to the normal olfactory
tissue we have also included one of the mouse models of KS, i.e.,
the Dlx5 null (14, 16, 47). We then used transgenic Zebrafishes
to image the olfactory axons and the GnRH neurons, and use
these to establish the function of Dlx5 targets for olfactory axon
extension/contact and on GnRH neuron migration and neurite
extension. The results confirm a role for Dlx5 and FGFR1, and
indicate Lrrn1 and Lingo2 as novel players for olfactory axon orga-
nization and for GnRH neuron migration. Finally, we applied
a gene prediction algorithm based on conserved co-expression
networks, on all known human and mouse KS-causing genes.
We predict a set of best candidates for causing, con-causing, or
modifying the KS/nCHH phenotype.
MATERIALS AND METHODS
MICE NULL FOR Dlx5
Mice with targeted disruption of Dlx5 have been previously
reported (50). The null allele, denominated Dlx5lacZ, allows
for detection of the Dlx5-expressing cells by staining for β-
galactosidase (β-gal) expression. The olfactory phenotype has been
previously characterized (14, 16, 47). To obtain the WT sam-
ples, only WT males and females were crossed. To obtain Dlx5
mutant samples, Dlx5+/− (heterozygous) males and females were
crossed; the progeny showed the expected Mendelian ratios of
genotypes+/+, Dlx5+/− and Dlx5−/−. Pregnant females were sac-
rificed at the chosen embryonic age by cervical dislocation. The
day of the vaginal plug was considered E0.5. All animal proce-
dures were approved by the Ethical Committee of the University
of Torino, and by the Italian Ministry of Health.
TISSUE COLLECTION FROMMOUSE EMBRYOS
Embryos were collected clean of extra-embryonic tissues (used
for genotyping) by manual dissection, transferred in RNAse-free
PBS, and further dissected to separate the head. This was then
included in 3% low-melting agarose in PBS, let harden and sec-
tioned by vibratome (250µm). Sections were manually dissected
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in cold PBS, with fine pins, to collect the OE or the VNO epithe-
lia, or alternatively to collect the adjacent mesenchyme (Figure S1
in Supplementary Material). The excised tissues were individu-
ally collected in RNA-later (Ambion) and stored at −20°C until
extraction. Following genotyping, samples of the same genotype
were pooled. For the Dlx5 mutant tissues, the entire epithelial lin-
ing of the nasal cavity was collected, since it was not possible to
discriminate the OE vs. the respiratory epithelium.
RNA EXTRACTION, LABELING, AND HYBRIDIZATION ON MOUSE
EXON-SPECIFIC ARRAYS
At least 15 embryos were used for each developmental age, the col-
lected tissues were pooled in three independent biological samples,
used to extract total RNA with the Trizol (Invitrogen).
After extraction, RNA samples were quantified using a
NanoDrop spectrophotometer (NanoDrop Technologies), the
integrity of RNA molecules was assessed by capillary electrophore-
sis on a Agilent Bioanalyzer (Agilent), and found to have a RIN
(RNA Integrity Number) value >5. One microgram of each total
RNA sample (in triplicate) was processed using the Affymetrix
platform’s instruments, following the GeneChip Whole Transcript
Sense Target Labeling procedure, according to instructions. Ribo-
somal RNA was depleted using the RiboMinus kit (Invitrogen),
cDNA was synthesized with random primers coupled with the
T7 Promoter sequence, using SuperScript II for first-strand syn-
thesis, and DNA Polymerase I for second-strand synthesis. The
cDNA was and used as template for IVT amplification, using
T7 polymerase. The amplificated products were used to syn-
thesize single-stranded cDNAs, with the incorporation of dUTP,
the products were fragmented by uracil-DNA-glycosylase (UDG)
and apurinic/apyrimidinic endonuclease-1 (APE 1) treatment.
Finally, 5.5µg of fragmented cDNA samples were biotinylated
with terminal deoxynucleotidyl transferase and used to hybridize
on GeneChip® Exon 1.0 ST Arrays (Affymetrix, Santa Clara,
USA). The Chips were washed and stained with Streptavidin-
phycoerithrin in the GeneChip Fluidic Station 450 and scanned
with Affymetrix GeneChip® Scanner 3000 7G.
ANALYSIS OF MICROARRAY DATA
Quality control was performed using the Affymetrix Expression
Console software1. All the experiments exhibited optimal qual-
ity controls and correctly clustered in the right sample groups;
they were thus all included in the analysis. Normalization and
probeset summarization steps were performed with RMA, within
the OneChannelGUI package (51) included in Bioconductor (52),
separately for each pairwise comparison including the six rele-
vant arrays (three biological replicates per condition). Differen-
tially expressed genes (DEG) for each pairwise comparison were
obtained with Rank Products (53), adopting a 0.05 false discovery
rate (adj. p-value ≤0.05).
SOFTWARES AND DATABASES
For preliminary Gene Ontology (G.O.) analyses we used DAVID2
and KEGG3. For improved categorization and visualization, we
1www.affymetrix.com
2http://david.abcc.ncifcrf.gov/
3http://www.genome.jp/kegg/pathway.html
used ClueGO (54). For the time course analysis we used default
parameters. For the analysis of down-regulated DEGs in the
Dlx5−/− samples we relaxed the analysis by using a cutoff of
0.001 on nominal enrichment p-value. For embryonic expression
of RefSeq genes we used the two on-line in situ hybridization
databases GenePaint4 and Eurexpress5. For the position weight
matrix (PWM) we used the JASPAR database. Tissue-specific con-
served co-expression networks were obtained with the TS-CoExp
Browser6 (55).
We also used the following web resources: Ensembl Genome
Browser7, UCSC Genome Browser8, RefSeq9, Mouse Genome
Informatix10, OMIM11.
GENOME-WIDE PREDICTION OF Dlx BINDING SITES AND PUTATIVE
TARGET GENES
With the PWM of Dlx5 provided by JASPAR under acces-
sion PH0024.1 (56) Dlx5 sites were predicted by standard log-
likelihood ratios, using as null model the nucleotide frequen-
cies computed over the whole intergenic fraction of the mouse
genome. We considered only those sites scoring 50% of the
maximum possible score or better. We selected sites that are
conserved in at least two (of eight vertebrate species). A site
is defined as conserved with species S if it lies in a region
of the mouse genome which is aligned with a region of the
S genome and the aligned sequence in/S/is a site according
to the same definition used for mouse sites. A ranked list of
putative Dlx5 targets was obtained from the identified sites as
described (57).
CONSERVED CO-EXPRESSION NETWORK, AND
PREDICTION/PRIORITIZATION OF PUTATIVE DISEASE GENES
Tissue-specific conserved co-expression networks were obtained
with the TS-CoExp Browser (see footnote text 6) (55, 58), based
on 5188 human and 2310 mouse manually annotated microar-
ray experiments. For disease prediction/prioritization we used
a tool within the TS-CoExp Browser and the same approach
based on conserved co-expression networks, but instead of
using genes causing similar phenotypes, we used KS-disease
genes as “reference” genes. These genes were selected based
on documented mutations in KS patients (for human) or well
described olfactory/GnRH embryonic phenotype recapitulating
KS (mouse).
VALIDATION OF ARRAY DATA BY REAL-TIME qPCR
Tissue samples corresponding to WT and Dlx5−/− OE were col-
lected from embryos at the age E12.5, transferred in RNA-later
in individual tubes and stored at −20°C. The genotype was
determined on extra-embryonic tissues. Samples were pooled
according to the genotype, collected in Trizol (Invitrogen), and
4www.genepaint.org
5www.eurexpress.org
6http://www.mbcunito.it/cbu/ts-coexp
7http://www.ensembl.org/index.html
8http://genome.ucsc.edu
9http://www.ncbi.nlm.nih.gov/RefSeq
10http://www.informatics.jax.org/
11http://www.omim.org/
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used to extract total RNA according to the instructions. For
Real-Time qPCR, 250 ng of total RNA was reverse-transcribed at
42°C for 50 min in the presence of 500 ng/µl random hexamers,
10 mM of each dNTPs, RNasin and Improm Reverse Transcrip-
tase (Promega). Relative cDNA abundance was determined using
the AB7900 System and the GoTaq qPCR Master Mix (Promega).
Specific cDNAs were amplified using primers and probes designed
according the Universal Probe Library system (UPS, Roche).
Experiments were repeated at least twice on independent sam-
ples, every point was done in triplicate, results were normal-
ized to the level of TATA-binding protein (TBP) and GAPDH
mRNAs. Data analysis was performed with ABI software, ver-
sion 2.1 (Applied Biosystems) using the comparative Cq method,
calculated with the formula of the DDCq. For each primer-pair,
the melting curves of the amplified products revealed a single
peak. Primer sequences are provided (Table S1 in Supplementary
Material).
ZEBRAFISH STRAINS AND GENE KNOCK-DOWN IN EMBRYOS
The following two strains were used for visualization of the olfac-
tory axons: OMP2k:gap-CFPrw034 and TRPC24.5k:gap-Venusrw037
(59–61), and were obtained from Drs. Nobuhiko Miyasaka and
Yoshihiro Yoshihara (RIKEN Brain Science Inst., Japan). The fish
strain GnRH3:GFP (62–64) was obtained from Dr. Y. Zohar (Uni-
versity of Maryland Biotechnology Institute, Baltimore, USA) and
Dr. Y. Gothilf (Life Sciences, Tel-Aviv University, Israel). Adult
fishes were maintained, bred and genotyped according to standard
procedures, kept under a 14 h-light and 10 h-dark photoperiod at
28°C. Allelic transmission followed the expected Mendelian ratios.
Following fertilization, 1-cell zygotes were collected and main-
tained in the presence of 0.003% 1-phenyl-2-thiourea (PTU) to
prevent formation of melanin.
To down-modulate specific genes, we injected antisense mor-
pholino oligos (MO) into zebrafish oocytes (65, 66). MO were
designed either to block splicing at a specific exon-intron junc-
tion (GeneTool oligo design), and consequently lead to present of
aberrant transcripts and frame-shifted translation, or to anneal
to the ATG start codon and inhibit translation initiation. For
z-dlx5a we combined two MOs: one annealing with the exon1-
intron1 splice junction and leading to a premature Stop codon
upstream of the homeodomain; the other annealing with the Start
codon. Sequences and properties of all the MO are in Table S2 in
Supplementary Material. Zygotes were collected at one-cell stage
and injected under stereological examination with 4 ng of MO,
in presence of Phenol Red for subsequent selection. From 48 to
72 h post fertilization (hpf) embryos were fixed with 4% PFA
at 4°C ON, washed in PBS, and embedded in 4% low-melting
agarose, 0.1% Tween-20. The apical portion of the head was man-
ually dissected from the rest of embryo. Confocal microscopy
analysis was performed using a Leica TCS SP5 (Leica Microsys-
tems). The OMP:CFP+ and the Trpc2:Venus+ (YFP+) axons
were viewed in a frontal plane, while the GnRH3:GFP+ neurons
were viewed in a ventral plane. Images were acquired as Z-stacks
of 1µm thick optical sections. Digital micrographs images were
contrast balanced and color matched using Photoshop7 (Adobe),
cropped, rotated, and assembled into figures with QuarkXpress
(Pantone).
RESULTS
GENES DIFFERENTIALLY EXPRESSED DURING OLFACTORY
DEVELOPMENT
We set forth to generate expression profiles of the OE at key stages
of its development, comprising the time of axonal connection.
We selected three developmental stages, i.e., the Olfactory Pla-
code (OPL) at E11.5, the OE at E12.5, and either the OE or the
VNO at E14.5. Mouse Affymetrix GeneChip® Exon 1.0 ST Arrays
were used to analyze the gene expression profiles of the develop-
ing olfactory (neuro)epithelium (OE). Comparing the OE E12 vs.
the OE at E11, with adj. p-value ≤0.05 and fold-change ≤−0.9
or ≥0.9, we found 29 up-regulated and 62 down-regulated genes.
Comparing the OE at E14 vs. the OPL E11 we found 358 up-
regulated and 17 down-regulated genes. Comparing the VNO E14
vs. the OPL E11 we found 459 up-regulated and 21 down-regulated
genes.
A fraction of the DEGs might derive from mesenchymal cells
present in the epithelial samples; as a matter of fact, epithelial
cells do not easily detach from the basement membrane and
mesenchymal cells inevitably tend to remain attached. A survey
of the embryonic expression territory of the modulated genes
using the on-line expression databases and www.genepaint.org
and www.eurexpress.org showed that about 10% of the DEGs was
indeed expressed in the nasal mesenchyme adjacent to the OE,
and not in the OE or VNO proper. Thus, we decided to estimate
the extent of mesenchymal contamination in the OPL, OE, and
VNO samples, by collecting pure mesenchymal tissue adjacent to
the OPL, OE, and VNO, at the same embryonic ages, and use the
RNA extracted from these to quantitatively determine the mRNA
abundance of “epithelial only” (FoxJ1, Fmo2, and Ehf) and “mes-
enchymal only” (Sp7 and Lect1) genes, by Real-Time qPCR. In
the same experiment we compared the samples of the OE (mixed
epithelium and mesenchyme) with“pure mesenchyme”samples at
the same embryonic age. The results indicate that the abundance of
a mesenchymal RNA in the OE samples is roughly 15% that of the
pure mesenchyme samples, thus we assumed that the contribution
of MES in the EPI samples is 15% (Figure S2 in Supplementary
Material).
At the same time, using the GeneChip® Exon 1.0 ST Arrays
and the same hybridization procedure and statistical analyses
used before, we generated profiling data from the MES sam-
ples collected from wild-type embryos at E11.5, E12.5, and
E14.5. At the age E14.5 the samples were collected adjacent to
the OE or adjacent to the VNO, according to their anatomical
position, and maintained separated. This effort was undertaken
to: (1) explore the global changes of expression that under-
lie interaction between the OE and the MES, (2) carry out
a subtraction step on the raw EPI data, to generate cleaner
OE data.
By comparing the MES samples at E12 vs. E11 we found 118
up-regulated and 17 down-regulated genes; comparing the sam-
ples OE at E14 vs. OPL E11 we detected 284 up-regulated and
41 down-regulated genes, while comparing the VNO at E14 vs.
OPL E11 we detected 293 up-regulated and 35 down-regulated
genes (the non-annotated probes are not included). Then we sub-
tracted the estimated expression of MES genes (15%) from the raw
expression data, applying this general formula to all genes present
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and expressed:
Eci
(
g
) = Ei (g )− F ×M (g )
where Ei(g ) is the expression of gene g in the i-th replicate of
the EPI dataset and M (g ) is the expression in the MES dataset,
averaged over all replicates. F is the estimated mesenchymal frac-
tion, equal to 0.15. Choosing F to be equal to 0.1 or 0.2 did
not significantly alter the results. With this calculation we created
a subtracted and corrected dataset with expression values more
indicative of the sole EPI expression. Comparing the corrected
EPI samples at E12 vs. E11 we found 9 up-regulated genes and
57 down-regulated; comparing the samples OE at E14 vs. OPL
E11 we detected 250 up-regulated and 19 down-regulated genes,
while comparing the VNO E14 vs. OPL E11 we detected 347 up-
regulated genes and 14 down-regulated (the non-annotated probes
and the OR genes are not counted). After the subtraction, a num-
ber of genes reached a “no expression” level. We assume that this is
due mainly to the fact that their differential expression was relative
to the MES. We examined how many of the genes that disappeared
from the raw list are up-regulated in the MES samples,and detected
highly significant enrichments (p < 4e–12).
The corrected lists of EPI DEGs up- and down-modulated in
the OE E14 vs. OPL E11 are reported in Tables S3 and S4 in Sup-
plementary Material, respectively, while the lists of DEGs up- and
down-modulated in the VNO E14 vs. OP E11 are in Tables S5
and S6 in Supplementary Material, respectively. In the OE we find
genes expected to be associated or to play a role in neuronal dif-
ferentiation and/or olfactory development, such as NeuroD, OMP,
Peripherin, NCAM2, Claudins, Keratins, and Lhx2 (a gene caus-
ing a KS-like phenotype in the mouse) (9). In addition we find
a set of olfactory receptor (OR) genes, as expected (Table S7 in
Supplementary Material).
Next we carried out functional categorization analyses on the
genes up-regulated in the OE, to identify enriched functional cate-
gories, using the Gene Ontology-based ClueGo tool (54, 67). Since
this analysis could be biased by the OR genes, which are numerous
(about 1000 in the mouse genome) and belong to a single cate-
gory, we masked the OR genes. The results are shown in Figure 1A.
From the comparisons OE 14 vs. OPL 11 we detect: regulation of
epithelial cell proliferation, regulation of cell migration, regula-
tion of extracellular matrix organization, and various categories
of response to signals.
In the VNO, we find several genes expected to be associ-
ated or to play a role in VNO development, such as NeuroD,
OMP, Lhx2, Peripherin, Claudins, Keratins, EphA3, Neuropilin1,
Lamininβ3, Lhx2 (a Kallmann gene in the mouse), and Dcx. In
addition we find several OR genes, as expected (Table S8 in Sup-
plementary Material). We carried out functional categorization
on the genes up-regulated in the VNO, after masking the differ-
entially expressed OR genes, and detected the over-represented
classes shown in Figure 1B. Focusing on the comparisons E14 vs.
FIGURE 1 | Continued
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FIGURE 1 | Functional categorization of genes differentially
expressed during normal OE and VNO development. Significantly
over-represented functional categories of DEGs detected in the
(corrected) EPI samples, comparing OE 14.5 vs. OPL 11.5 (A) or
comparing the VNO 14.5 vs. OPL 11.5 (B) were organized them in
networks using ClueGO. Only the results of the up-regulated DEGs are
shown. Circles represent over-represented categories, lines indicate
related categories.
E11, we detect: regulation of epithelial cell proliferation, regulation
of cell migration, regulation of cell adhesion, gland and epithelium
morphogenesis, cartilage development, bone development, extra-
cellular matrix organization, and various categories of response to
signals.
DEGs IN OLFACTORY-ASSOCIATED MES, DURING DEVELOPMENT
We then compared the profiles of the MES samples across the
developmental ages E11.5–E12.5–E14.5. The full lists of up- and
down-modulated DEGs relative to the OE are provided in
Tables S9 and S10 in Supplementary Material, respectively, while
the full lists of up- and down-regulated DEGs relative to the
VNO are provided in Tables S11 and S12 in Supplementary Mate-
rial, respectively. We recognized genes playing a role in cell–cell
communication, signaling, matrix remodeling, etc. such as Inte-
grins, Contactins, Matrillins, Tenascin, Collagens, MMPs, Adams,
Lectin Galactose Binding 9, Elastin, FGF7, FGF12, Sfrp2, Sfrp4,
Sema3D, Sema3C, Nrp1, Wnt2, Bmp5, Follistatin. We also found
Frontiers in Endocrinology | Experimental Endocrinology December 2013 | Volume 4 | Article 203 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Garaffo et al. Olfactory and GnRH development
some neuronal genes, likely due to a minimal presence of olfactory
neuron in the MES sample and to the presence of migratory GnRH
neurons in the E14 sample, minimal in the E11 sample. Functional
categorization on these DEGs detected an enrichment of the fol-
lowing categories: extracellular matrix organization, cell-substrate
adhesion, cartilage and bone development, organ morphogenesis,
response to signals, and some neuronal categories (Figures 2A,B).
PROFILING OF THE Dlx5−/− VS. WILD-TYPE OE
The Dlx5−/− mutant mice represent a fully penetrant model of
KS (14, 16, 47). Triplicates of the OE and VNO tissues were col-
lected from WT and Dlx5−/− embryos at the age E12.5, total
RNA was extracted and hybridized on the GeneChip® Exon 1.0
ST Arrays. Using the indicated statistical parameters (see Materi-
als and Methods) we detected 121 down- and 25 up-regulated
genes in the Dlx5−/− OE vs. the WT, not counting the non-
annotated probes and the OR genes (Figure 3A; Table S13 in
Supplementary Material). Again, the OR genes were removed
(provided in Table S14 in Supplementary Material) prior to con-
ducting functional categorization analysis by G.O. We detected:
intermediate filament/cytoskeletal organization, endocrine sys-
tem development, forebrain development, cell–cell signaling, and
epithelial cell differentiation (Figure 3B).
We carried out a technical validation of the microarray results,
by selecting 12 down- and 4 up-regulated DEGs and quantifying
their expression on independently collected samples, by Real-
Time qPCR. Of these DEGs, 11 down- and 2 up-regulated were
confirmed (Figure 3C).
Next we verified whether the identified DEGs are expressed in
the OE, in the adjacent mesenchyme, or in both, by consulting the
on-line expression databases GenePaint and Eurexpress. We classi-
fied DEGs as either not expressed (−), expressed in the neurepithe-
lium (NEp), expressed in the mesenchyme (Mes), expressed in the
respiratory epithelium (Res) or ubiquitously expressed (Ub). We
assumed that the OR were all expressed in NEp,and in any case they
were excluded. Among the 72 down-modulated DEGs considered,
FIGURE 2 | Continued
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FIGURE 2 | Functional categorization of genes differentially expressed in
the mesenchyme adjacent the OE and VNO, during development.
Significantly over-represented functional categories of the DEGs detected in
the mesenchymal tissue associated with the OE 14.5 vs. OPL 11.5 (A) or
associated with the VNO 14.5 vs. OPL 11.5 (B) were organized in networks
using ClueGO. Only the results of the up-regulated DEGs are shown.
50 (69%) have a NEp expression, 14 (19%) are not expressed in the
OE, 4 (5%) have a Mes expression, 3 (4%) have a Res expression,
and 2 (3%) are ubiquitously expressed. Thus, conclude that the
majority of down-modulated genes are expressed in the OE.
Then we examined whether the DEGs were differentially
expressed also in other mouse tissues upon loss of Dlx5, specifically
the inner ear and the pharyngeal arches (68, 69). No common DEG
was found, indicating that Dlx5 targets are strongly tissue-specific.
Next we examined whether the olfactory DEGs we detected were
also differentially expressed in other published mouse models of
KS, i.e., the Klf7 and the Emx2 mutants (70, 71). Three genes were
found commonly differentially expressed the three models, namely
stathmin-like 3, synaptotagmin 1, and calmegin, all expressed in
the embryonic OE. Fifty genes were in common between Dlx5
and Emx2 datasets, seven were in common between Emx2 and
Klf7, and one was in common between Dlx5 and Klf7. However it
should be noted that the profiles of the Emx2 and Klf7 mutants
were obtained from the OB and not the OE.
The DEGs up-regulated in the absence of Dlx5 are enriched
in generic terms: biosynthesis, metabolic processes, morphogen-
esis. Of the 27 DEGs considered, 14 (52%) are expressed in the
Mes, 6 (22%) are not expressed in the OE/VNO, 3 (11%) have a
Res expression, 2 (7.5%) are expressed in the OE, and 2 (7.5%)
are ubiquitously expressed. Thus, we conclude that most of the
up-regulated DEGs are not expressed in the OE. Since the Dlx pro-
teins are generally considered transcription activators (72, 73), the
interest in these DEGs is low and they were not further considered.
GENOME-WIDE PREDICTION OF Dlx5 BINDING SITES AND
TRANSCRIPTIONAL TARGETS
Using the consensus PWM for Dlx5 (56) (Figure S3 in Supple-
mentary Material) we screened conserved regions of the vertebrate
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FIGURE 3 | Genes differentially expressed in the Dlx5−/− OE vs.
wild-type OE. (A) Heatmap and cluster analyses on the MicroArray
data, after elimination of non-annotated genes and of the OR
genes. The triplicate Dlx5− /− (KO) and wild-type (WT) samples are
indicated at the bottom. (B) Gene Ontology to detect
over-represented functional categories. (C) Validation by Real-Time
qPCR on selected down-regulated genes, done on independently
collected samples. The abundance in the wild-type tissue is set=1.
For each gene, the fold-change determined by MicroArray
hybridization is also reported.
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genome and detected putative Dlx5 binding sites. We attributed to
each site a score that reflects the number of species in which the site
is conserved. We then associated the sites to an associated Refseq
transcripts and found 3,426 RefSeq targets, corresponding to 2,683
unique Entrez-IDs [see Materials and Methods, and Ref. (57)].
The top scoring RefSeq are reported in Table S15 in Supplemen-
tary Material. We then categorized the predicted Dlx5 targets by
ClueGO (54), and detected an enrichment categories such as neu-
ronal differentiation, brain development, etc. as expected [there is
ample literature on this; see Ref. (73)].
We then intersected the best predicted Dlx5 targets (having
at least one binding site conserved in at least three mammalian
species, and located <10 kb from the TSS) with the list of DEGs
obtained comparing Dlx5−/− vs. WT OE, and we found that 16%
of the down-regulated DEGs (19/121; p= 0.0003) were indeed
predicted target of Dlx5, while 40% of up-regulated DEGs (9/21;
p= 0.00019) were predicted targets. In both cases statistical signif-
icance was reached. This suggests that the prediction algorithm we
have used is sensitive and sound. To restrict the number of candi-
date genes we intersected the profile datasets with: (a) embryonic
expression databases, (b) conserved co-regulations, (c) predicted
Dlx5 sites and target RefSeq, (d) data from published literature,
in order to assign a score value to each DEG (Tables 1A–E). The
expression of these putative Dlx5 targets in the embryonic OE
and nasal region, by in situ hybridization (see footnote text 4)
is reported in Figure S5 in Supplementary Material. Some of the
most functionally relevant genes are briefly described below:
Lrrn1 codes for a transmembrane protein related to Drosophila
TRN/CAPS proteins, known play a role in neuromuscular tar-
get recognition, and to mediate interactions between incoming
axons and the targets, possibly via homophilic adhesion. Lrrn1 is
expressed in the mouse embryonic OE.
Lingo2 (also known as Lrrn6c) codes for a transmembrane pro-
tein, expressed in the OE and in the ventricular region of the
embryonic forebrain. Lingo proteins interact with the NOGO
receptor and are able to modulate the NOGO pathway (74),
however their precise functions are poorly known.
Lgi1 codes for a leucine-rich repeat secreted molecule of the
SLIT family, involved in growth of neuronal processes on myelin
substrates (75, 76).
St8siaVI is expressed by olfactory neurons and might be
implicated in polysialylation the N-CAM to confer anti-adhesive
properties to neuronal surfaces (77–79).
Homer2 codes for a protein present at post-synaptic density,
likely to be involved in receptor clustering and trafficking, as well
as calcium homeostasis (80). Recently, a role of Homer2 in tun-
ing the activity of G protein-coupled receptors (such as ORs) has
been reported (81). Homer2 is expressed in the OE of the mouse
embryo, however its function is unknown.
TESTING Dlx5, Dlx5 TARGETS, AND KS GENES IN ZEBRAFISH STRAINS:
THE OLFACTORY AXONS
The development of olfactory system is well conserved during
vertebrate evolution (27, 35, 82) and consists of two indepen-
dent components: the main OE for detecting chemical com-
pounds (odorants) and the VNO-accessory system for detecting
pheromones. Fishes and primates lack a VNO organ and present
only one olfactory organ, the OE (83). Within the OE of the fish,
all ORNs project their axons to the OB – at different region in a
mutually exclusive manner (60) – but display distinct properties
with respect to their morphology, relative position in the OE, and
molecular expression. The ciliated OSNs with long dendrites are
situated in the deep layer of the OE, whereas microvillous ORNs
with short dendrites are located in the superficial layer. The cili-
ated and microvillous ORNs are reported to express OR-type and
V2R-type receptors, respectively (84, 85).
We opted to use Danio rerio (zebrafish) as a model to func-
tionally examine in vivo the identified DEGs for their role in
olfactory/GnRH development. We used two transgenic zebrafish
strains expressing distinct fluorescent proteins in the fish olfac-
tory neurons (59–61). In one strain the CFP reporter is expressed
under the control of OMP promoter, which marks the majority
of basal-layer ORN, projecting their axons to the dorsal OB. In
the other strain, the Venus (YFP) reporter is expressed under the
control of the Trpc2 promoter, which marks a sub-population of
apical-layer ORN, projecting to the ventro-lateral OB (scheme in
Figure S4 in Supplementary Material) (60). The CFP+ and the
Venus+ (YFP+) neurons are thought to correspond, respectively,
to the OE and VNO receptors of the mammalian system. Since
the reporter fluorescent proteins are efficiently translocated in the
ORN axons, these two strains visualize the peripheral olfactory
pathway.
We tested z-fgfr1a, the fish ortholog of mammalian FGFR1,
to establish whether its depletion recapitulates the hallmarks of
KS. Notably, mice hypomorphic for FGF8 expression show dis-
tinctive signs of a KS phenotype, i.e., impaired migration of
GnRH+ neurons and defects in olfactory development (41, 42).
We injected z-fgfr1a MOs in 1-cell embryos of the OMP:CFP and
the Trpc2:Venus strains, and 72 hpf we examined the number of
fluorescent embryos, the organization of the OPL, the fascicula-
tion, extension and glomeruli formation. In 61% (32/52) of the
embryos we observed an altered morphogenesis of the OPL and
an abnormal distribution of the CFP+ and the Venus+ neurons
within the OLP (Figure 4); we defined this phenotype as “pla-
code defect.” In 30% (16/52) of cases we observed bundles of
OE-type and VNO-type axons either overshooting past the OB or
taking a misguided route (arrows in Figure 4). We also observed
lack or impairment of connection with the OB, as indicated by
the absence of typical glomerulus structures or their disorganized
position at the OB (asterisks in Figure 4). We collectively defined
these phenotypes as “connectivity and glomeruli defect.” None of
these phenotypes were seen in control embryos.
z-dlx5a is the fish ortholog of mammalian Dlx5, in fact the
embryonic expression territory is similar (86), and its knock-
down causes craniofacial and neuronal phenotypes resembling
the Dlx5−/− phenotype in mice (87, 88). We depleted z-dlx5a in
zebrafish embryos using a combination of two MO, and exam-
ined the organization of olfactory axons. Following MO injection,
72 hpf we recovered about 50% of CFP+ embryos (95% of the
control injected) and about 72% of Venus+ embryos (78% of
the controls). In 45% of cases (of 80 examined) we observed
OPL defects, while in 54% of cases we observed OE-type and
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Table 1 | Best Dlx5 target gene, selected combining the profiling results with PWM-based site prediction and embryonic expression.
Gene title Gene symbol log2.FC. Dlx site Express Score Notes
(A) SURFACE RECEPTORS/ADHESION MOLECULES OR MODIFIERS
Leucine-rich repeat and Ig
domain containing 2
Lingo2 −1.3995539 + N Ep 5 Structure similar to other Receptor Tyrosine
Kinases, such as Trk. Associated to higher risk of
tremor and Parkinson. Lingo1 is a component of
the NOGO-66 receptor and may play a role in
neurite outgrowth and oligodendrocyte
differentiation
Leucine-rich repeat LGI
family, member 1
Lgi1 −1.355411 + N Ep 5 Secreted molecule of the SLIT family, promotes
formation of stress fibers. Inhibits cell movement
and invasion. Enhances growth of neuronal
processes on myelin-based substrates. Its
receptor forms complexes with Adam22
Leucine-rich repeat protein 1,
neuronal
Lrrn1 −1.032383 + N Ep 5 Transmembrane protein of unclear function.
Regulates neurite growth
Ig superfamily containing
leucine-rich repeat 2
Islr2 −0.9967503 + Not/migr cell 4 Also known as Linx, could be a Receptor Tyrosine
Kinase evolutionarily related to Trk receptor.
Modulates axon extension and guidance
ST8 α-N -acetyl-neuraminide
α-2,8-sialyltransferase VI
St8siaVI −1.3472121 + N Ep 4 Sialo-transferase expressed by neurons, essential
for surface functions during neurite growth and
neuronal migration
(B) SCAFFOLD INTRACELLULAR PROTEINS
A kinase anchor protein 6 Akap6 −1.5186358 + N Ep 5 Protein Kinase A-anchoring proteins. Serves as
scaffold to bring together PKA and PDE and
coordinate the timing and intracellular localization
of cAMP signaling. Also binds to- and
modulates-signaling through ERK, MAPK, and
PP2A
Dual adaptor for
phosphotyrosine and
3-phosphoinositides 1
Dapp1 −1.2094534 N Ep 4 Signaling adapter molecule, coordinates timing
and location of signaling by PIP3 and PIP2 with
that of ERK. Also binds F-actin and Rac
RIKEN cDNA 9330120H11
gene
9330120H11Rik −1.1589186 N Ep 4 Also known as HOMER 2, present at
post-synaptic density, involved in receptor
clustering, trafficking, and in calcium homeostasis
(C) SYNAPTIC PROTEINS
Synaptosomal-associated
protein 25
Snap25 −1.3481758 + N Ep 5 Controls membrane trafficking and fusion at the
growth cone and at the synapse. Implicated in
neuroblast migration and neuritogenesis during
development. Forms complex with p140CAP
which also binds to p130 CAS
γ-Aminobutyric acid (GABA) A
receptor, subunit β 2
Gabrb2 1.0063619 + N Ep 5 Receptor subunit for GABA. GABA-b receptors
mediate signals inhibitory for olfactory axon
elongation
Receptor transporter protein 1 Rtp1 −1.6548021 N Ep 4 Chaperon, required for the efficient translocation
of OR molecules to the membrane. Interacts with
the OR and with Homer
RIKEN cDNA 9330120H11
gene
9330120H11Rik −1.1589186 N Ep 4 Also known as Homer2, present at post-synaptic
density, involved in regulation of calcium fluxes
and homeostasis
(Continued)
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Table 1 | Continued
Gene title Gene symbol log2.FC. Dlx site Express Score Notes
(D) AXON-GLIA INTERACTION PROTEINS
Fatty acid binding protein 7,
brain
Fabp7 −1.9620307 N Ep-Gliale 4 Known as BLBP in human. Controls surface
functions that are required for axon-Schwann cell
interaction. May be involved in peripheral axon
elongation and regeneration
Ermin, ERM-like protein Ermn −1.5033487 N Ep/Sust
cell
4 Also known as Juxtanodin. Expressed in
sustentacular cells, binds to F-actin and stabilizes
the actin cytoskeleton. In the CNS promotes
myelination
Ganglioside-induced
differentiation-associated-
protein 1
Gdap1 −1.1935825 + N Ep/Res 4 Involved in the Charcot-Marie tooth disease, in
particular those forms with axonal deficits.
Cellular function unclear
UDP Galactosyltransferase 8A Ugt8a −1.1139671 + 4 Important for the biosynthesis of galacto-lipids
and in myelin formation
(E) CALCIUM-REGULATION
Cyclic nucleotide gated
channel α 2
Cnga2 −1.129349 + N Ep 5 Regulate axon extension and glomerular
formation. KO mice have behavioral defects
possibly linked to olfactory functions
Visinin-like 1 Vsnl1 −1.3860936 + N Ep 4 Also known as GP2. Calcium-regulated guanylate
cyclase transduction system. Play a role in
adaptation. Inhibits the formation of cAMP. May
affect dendrite and growth cone arborization
Genes are sub-divided in five general categories (A–E).
VNO-type axons targeting abnormal regions of the head near the
OBs, often overshooting past the OB (arrows in Figure 4). We
also observed impaired axon-OB connections, as judged by the
absence of glomeruli-like bundles or their disorganized position
(asterisks in Figure 4). None of these phenotypes were seen in
non-injected or control MO-injected embryos. Thus, the deple-
tion of z-dlx5a causes defects that recapitulates key aspects of the
Dlx5−/− phenotype (14, 16, 47).
Next we focused on the putative Dlx5 targets Lrrn1,Lingo2, Islr1,
St8siaVI, and Homer2, whose embryonic expression in the brain
and olfactory system is reported in Figure S5 in Supplementary
Material. We depleted z-lrrn1 in 1-cell zygotes by MO injection.
Of the injected embryos, only approximately 50% were recovered
and positive for OMP:CFP (vs. 85% in the control injected), and in
a majority of these (75% of a total of 62 examined) we observed a
reduction of the CFP+ signal intensity. On the contrary, we recov-
ered a not significantly different percentage of Venus+ embryos
(71 vs. 78% in the control injected) and these occasionally (20%)
showed a reduced YFP fluorescent signal (Figure 5). Twenty per-
cent of z-lrrn1 MO-injected embryos displayed placode defects,
consisting in a reduced size, altered shape, and mispositioned neu-
ron. Half of the z-lrrn1 MO-injected embryos displayed an altered
pattern of olfactory axon fasciculation and extension, with axons
overshooting or taking an ectopic route (arrows) and reduced or
absent glomeruli (asterisks). Thus, the depletion of z-lrrn1 results
in a delayed differentiation of the OMP+ type olfactory neurons
and altered olfactory axons trajectory and connectivity, hallmarks
of the phenotypes observed in Dlx5−/− mice and in z-dlx5a fish
morphants.
Next we depleted z-lingo2 in reporter zebrafish embryos. Injec-
tion of the anti-z-lingo2 MO in 1-cell embryos caused minor OP
defects, consisting in altered organization and shape, while axon
trajectory and glomeruli formation appeared normal (Figure 6).
Next we depleted z-st8SiaVI in zebrafish embryos. Injection of
the anti-z-st8siaVI MO in 1-cell embryos resulted in a pheno-
type affecting axon extension, trajectory, and glomeruli formation
(Figure 6). Next we depleted Homer2 in the reporter fish embryos.
Injection of the anti-z-homer2 MO in 1-cell embryos resulted in
defects of OP organization and axonal targeting, plus also resulted
in a reduced expression of Trpc2, seen as reduced YFP fluorescent
signal (Figure 6). This last result might indicated that z-homer2 is
involved in the differentiation of the VNO-type neurons, and its
depletion may delay this process. Finally, the depletion of z-islr1
yielded no appreciable phenotype affecting the olfactory pathway
(data not shown). This gene is not expressed in the embryonic OE
(Figure S5 in Supplementary Material).
TESTING Dlx5, Dlx5 TARGETS, AND KS GENES IN ZEBRAFISH STRAINS:
THE GnRH NEURONS
To determine whether some of the DEGs that emerged from
transcription profiling of Dlx5 mutants had some function of
GnRH neuronal migration and neurite organization, we used the
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FIGURE 4 | Depletion of endogenous z-dlx5a and z-fgfr1a in zebrafish
embryos, to image the olfactory axons. (A) Micrographs of Trpc2:Venus
(YFP, yellow fluorescence) and OMP:CFP (cyan fluorescence) fish embryos
injected with a control MO (top panels), injected with anti-z-dlx5a MO (middle
panels) or injected with anti-z-fgfr1a MO (bottom panel). White arrows and
lines indicate the normal axonal pathway in control embryos. Red asterisks
indicate absence of glomeruli. Red arrows indicate altered axonal trajectories.
(B) Whole-mount bright field micrographs of injected embryo, showing an
overall normal embryonic morphology and growth rate in the injected
embryos, compared to control injected ones. (C) Proportions of embryos
showing either placode defects (OPL disorganization, altered neuron
distribution), or connectivity/glomeruli defects (altered axon trajectory, altered
fasciculation, reduced or absent glomeruli), or both, upon injection of control
(open bars), anti-z-dlx5a (gray bars), or anti-z-fgfr1a (solid black bars) MOs.
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FIGURE 5 | Depletion of endogenous z-lrrn1 in zebrafish embryos, to
image the olfactory axons. (A) Micrographs of Trpc2:Venus (YFP, yellow
fluorescence) and OMP:CFP (cyan fluorescence) zebrafish embryos
injected with control (top panels) or with anti-z-lrrn1 (bottom panels) MOs.
The control MO did not cause any significant alteration. White arrows
indicate the normal axonal pathway and glomeruli in the control embryos.
Red asterisks indicate absence of glomeruli. Red arrows indicate altered
axonal trajectories. (B) Whole-mount bright field micrographs of injected
embryo, showing normal embryonic morphology and growth rate.
(C) Proportions of embryos showing either OPL disorganization, or
olfactory axon mistargeting, or both (last bars) upon injection of control
(open bars) or anti-z-lrrn1 (gray bars) MOs.
GnRH3:GFP transgenic zebrafish strain, previously reported (62–
64). In these animals the GFP reporter is expressed under the tran-
scription control of a fragment of the fish GnRH3 promoter. The
GnRH3-GFP+ neurons have been widely characterized, and they
consist in a population of terminal nerve associated GnRH+ neu-
rons, thought to represent the mammalian hypothalamic neurons
with olfactory origin (27, 62–64, 89) (Figures 7A,B).
We depleted z-dlx5a, z-fgfr1a/b, and z-lrrn1 in the GnRH3:GFP
1-cell zygotes, and examined the effect on the number, position,
neurite organization, and commissure formation of the GFP3+
neurons associated to the terminal nerves. The depletion of z-dlx5a
resulted in a reduced number of GFP+ neurons in 30% of cases,
and in 70% of cases clearly appeared mispositioned (40 morphants
examined) (Figures 7C,D; quantifications in 7G). However, the
depletion of z-dlx5a did not affect the ability of GFP+ axons to
cross the midline at the anterior commissure. Thus, a reduction
of z-dlx5a in the fish model recapitulates (some of) the GnRH
phenotype observed in the mouse model (16, 47).
The depletion of z-fgfr1a/b resulted in a reduced number
of GFP+ neurons in 80% of cases (a total of 40 morphants
examined), and in 22% of cases these neurons were clearly
mispositioned, and had shorter neurites (Figure 7E). In 35% of
cases the GnRH+ neurites failed to properly cross the midline in
the anterior commissure. This phenotype recapitulates that seen
upon depletion of z-kal1a/b (45, 46), thus we conclude that, based
on the results of two well-established KS/nCHH genes and one
KS-causing gene in the mouse, the use of MO in the GnRH3:GFP
strain is a valid approach to examine the KS phenotype in vivo, and
assures that future analyses on this subject will be informative.
The depletion of z-lrrn1 in the GnRH3:GFP fish embryo caused
a reduction in the number of GFP+ neurons in 45% of cases,
and in 65% of cases caused their misposition along the terminal
nerve (40 morphants examined) (Figure 7F). We also observed
a reduction of their neurite length, but little of no defect of the
anterior commissure. Thus also one Dlx5 target is involved in the
organization and the maturation of the olfactory/GnRH system.
BIOINFORMATIC PREDICTION/PRIORITIZATION OF NEW KALLMANN
DISEASE GENES
A large set of genes has been found mutated, alone or in com-
bination, in KS/nCHH patients, by classical mutation search
approaches. However, with the exception of KAL1 and FGFR1,
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FIGURE 6 | Olfactory and VNO axons, upon depletion of endogenous
z-St8siaVI, z-lingo2, and z-homer2 in zebrafish embryos. (A) Micrographs
of Trpc2:Venus (yellow fluorescence) and OMP:CFP (cyan fluorescence)
embryos injected with control MO (top panels), or injected with
anti-z-st8siaVI, anti-z-homer2, anti-z-dapp1, and anti-z-lingo2 MOs, as
indicated on top of each image. The control MO did not cause significant
alterations. Arrows indicate altered axonal trajectory, asterisks indicate
absence of glomeruli or altered OPL organization. Asterisks indicate the
regions of reduced fluorescence intensity. (B) Whole-mount bright field
micrographs of injected embryo, showing normal morphology and growth
rate. (C) Proportions of embryos showing either placode defects, connectivity
and glomeruli defects, or both, upon injection of the MOs indicated above
(colored bars), compared to control MO (open bars). Asterisks indicate
statistical significance.
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FIGURE 7 |The GnRH3 neurons upon depletion of endogenous
z-dlx5a, z-fgfr1a, and z-lrrn1 in zebrafish embryos. (A) Scheme
showing the positions of the GnRH3:GFP+ neurons (green cells),
relative to the OPL, the OB, and the olfactory nerves (yellow and blue),
in a frontal view. The anterior commissure is shown at the basis of the
OB. On top, a scheme illustrating the view plane (frontal) used in (A).
(B) Scheme illustrating the view plane (ventral) used for the fluorescent
images in (C–F). (C–F) Micrographs of GnRH3:GFP zebrafish embryos,
at 60 hpf, injected at the 1-cell stage with either a control MO (C), with
anti-z-dlx5a MO (D), with anti-z-fgfr1a MO (E), or with anti-z-lrrn1 MO
(F). Insets on the lower right of each panel is a low-magnification
merged micrograph (bright field and GFP fluorescence) of the higher
magnification one. Red asterisks indicate reduced number of cells, red
arrowheads indicate scattering and delayed cell migration, white
arrowheads indicate the anterior commissure, white asterisks indicate
absence of anterior commissure. (G) Quantification of the observed
phenotypes, as percent over the total number of GFP+ embryos
examined with each MO.
each of them is mutated in a small fraction of the patients, and
together account for no more than 40% of KS/nCHH cases. Five
novel genes, functionally linked to FGF8, have been recently iden-
tified using predictive bioinformatics followed by mutation search
in patients’ DNAs (7). With the exception of some genes evidently
linked (Prok2 and ProkR2; FGF8 and FGFR1; GnRH and GnRH-
R) the remaining genes appear to be unrelated, or distantly related
on a functional basis. We reasoned that relationships might exist
between the KS-disease genes that are not obvious, or not easily
detected, or that genes may have pleiotropic functions, not know
as yet. Tools have been developed that search for such relationships
in databases or newly generated data, and can be used to propose
candidate disease genes (90).
HUMAN NETWORK
We compiled a list of genes known to cause KS, or KS and
nCHH, excluding those causing only nCHH; the list included
FGFR1, FGF8, KAL1, PROK-2, PROKR2, CHD7, GnRH, GnRH-
R, HS6ST1, TAC3, TACR3, SOX10 e SEMA3a. We also included
FLRT3, IL17RD, FGF17, SPRY4, DUSP6, members of the “FGF8
synexpression” group (7) and named all these “human reference
genes.” First we searched for the presence of the reference genes
among the DEGs from the Dlx5−/− OE vs. WT, however none
of them was found. Likewise, we searched for the presence of
these genes among the DEGs from the time course of the nor-
mal OE and VNO. With the exception of GnRH, none of the
other genes was found. Next, we positioned the “human refer-
ence genes” within the global conserved co-expression network,
using TS-CoExp (with the exception of KAL1/anosmin1 that lacks
a mouse ortholog and for which the conservation criterium cannot
be applied) (Figure 8A).
The network representation does not consent per se to derive
relevant information. Instead, from the data we extracted those
genes connected with at least six (N = 2), at least five (N = 3), at
least four (N = 10), at least three (N = 45), at least two (N = 317),
and at least one (N = 1977) reference genes. We then categorized
these genes by G.O. and detected an enrichment of the following
G.O. categories: phosphoproteins, kinase/transmembrane recep-
tors, cell adhesion, cell junctions, regulation of cytoskeleton, cell
migration/motility, neuronal projection. Among the most con-
nected ones we did not find any gene causing KS in mice, but we
identify TRIM2, GATAD2A, SNRPN, and CDH2. Being expressed
in the embryonic OE (Figure S6 in Supplementary Material), these
represent most interesting genes.
Next, we used the disease gene prediction tool of TS-CoExp
to identify novel candidate KS genes: the “human input genes”
were taken as reference to independently prioritize the follow-
ing DEG lists: (a) Dlx5−/− OE vs. WT at E12; (b) EPI OE 14 vs.
OPL E11 (WT); (c) EPI VNO 14 vs. OPL E11 (WT); (d) MES
OE14 vs. OPL E11 (WT); (e) MES VNO 14 vs. OPL E11 (WT).
From the DEG list (a) we found nine genes significantly associ-
ated with the KS phenotype, three of which (RGS5, F2RL1, and
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DPF3) are expressed in the embryonic OE, while two (GATA3 and
ADAMTS5) are expressed in the olfactory mesenchyme (Figure S6
in Supplementary Material).
From the DEG lists (b) and (c) we found 21 and 73 genes respec-
tively, significantly associated with the KS phenotype, 19 of which
are present in both lists, and the majority of these are expressed in
the nasal mesenchymal. Notably, the search predicted two genes
known to cause KS in the mouse, namely Ebf2 and Nrp1, con-
firming that our analysis is in principle correct. From the DEG
lists (d) and (e) we found 47 and 189 genes respectively, signifi-
cantly associated with the KS phenotype, 27 of which are present
in both lists. Among these, 50% show expression in the embry-
onic OE (ACAN, AKAP6, ATF5, KRT18, MYT1L, NDRG1, NRXN1,
SYT1, and TPD52) and 50% in the olfactory-associated mes-
enchyme (ANXA1, DCN, FCGRT, PAPS2, PTRF, RUNX1, S100b,
and TGM2). Notably, the search predicted two genes known to
cause KS in the mouse, namely Ebf2 and Nrp1. Furthermore,
we found genes such as AKAP6, LINGO2, LGI1, and LGI2 that
were found among the Dlx5 targets in the OE, and SEMA3C and
MET, known to play a role in axon guidance and cell migration,
respectively.
MOUSE NETWORK
We applied the approach previously used to those genes causing
a KS-like phenotype in mice; the list included Dlx5, Emx2, Klf7,
Fezf1, Six1, Prok2, ProkR2, Lhx2, Shep1, Ebf2, Nrp1, and Sema3a.
None of them was found in the DEG lists from the Dlx5−/− OE
vs. wild-type, and none was found in the DEG list from the time
course of the normal OE and VNO, with the exception of Lhx2
and GnRH. We positioned the mouse reference genes within the
conserved co-expression network (with the exception of Fezf1 for
which no result was obtained) (Figure 8B), and extracted lists of
genes connected with at least five (N = 1), at least four (N = 3),
at least three (N = 33), at least two (N = 261), and at least one
(N = 1850) of them. These genes were then categorized by G.O.
and we detected these over-represented terms: phosphoproteins,
cell adhesion/cell junctions, neuronal projection, cell motility,
cytoskeleton regulation, transcription regulation.
FIGURE 8 | Continued
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FIGURE 8 | Disease gene networks for KS. (A) Position of the human
KS-causing genes within the global conserved co-expression network, as
computed with the TS-CoExp algorithm. (B) Position of the genes causing a
KS-like phenotype in mice, within the global conserved co-expression
network. The lists of the input (human and mouse) “disease” genes used for
these analyses are in the text. For simplicity, only the genes connected with
at least three input genes are shown; the genes connected with “at least
one” or “at least two” input genes are available upon request. Green circles
represent the input genes, pink circles represent the connected genes, lines
represent statistically significant co-regulations.
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Next, for each of the four DEG list (from the profiling results,
see above), we used the disease gene prediction tool in TS-CoExp
to identify those genes most likely to be involved in KS, using the
mouse reference genes as input. From the (a) list we found 13
genes, two of which (Scn3B and Sv2B) are expressed in the OE,
while two (Adamts5 and Wnt5a) are expressed in the olfactory
mesenchyme (Figure S6 in Supplementary Material). From the (b)
and (c) lists we found 19 and 65 genes respectively, 17 of which are
present in both lists. Most are expressed in the nasal mesenchyme.
Contrary to the human network, the mouse network did not pre-
dict any human KS gene. From the (d) and (e) lists we found 65
and 41 genes respectively, 17 of which are present in both lists and
most of these are expressed in the nasal mesenchyme. Also in this
case, we could not predicted any human KS genes. We found two
genes: Dcx and Lrrtm, the first is relevant for migration of imma-
ture neurons, the second codes for a leucine-rich repeat protein
similar to Lrrn1.
Finally, considering both the human and the mouse reference
genes, five genes were found in at least three lists of genes associated
with KS, namely Dcn (Decorin), FGF7, Aspn, Ptfr, and Ntrk2. Three
of these, Ntrk2, Dcn, and Ptfr are clearly expressed in the juxta-
OE and VNO mesenchyme, Aspn is ubiquitously expressed and
the expression of FGF7 is unclear. FGF7 codes for a growth factor
related to FGF22, the literature reports indications that it functions
as pre-synaptic organizing molecule during hippocampal develop-
ment (91, 92) and is needed for migration of enteric neurons (93).
Its function in the developing OE is unknown. In conclusion, the
most promising predicted KS genes are mesenchymally expressed.
This is not surprising, considering that in all our profiling results,
the prevalent categories are cell–cell and cell-matrix interactions,
remodeling, signaling, etc. . .
Note: all gene lists, categorizations or tables not included in the
manuscript or as supplementary material are available on request.
All data are deposited at GEO repository, N° GSE52800.
DISCUSSION
Kallmann syndrome and nCHH are developmental/pediatric con-
ditions phenotypically well characterized, however less well under-
stood molecularly. Despite the number of genes found mutated in
KS/nCHH patients, the majority of them still await a molecu-
lar definition. Thus, there is a strong basis to predict that many
additional disease loci remain to be identified. Furthermore, the
mutations found in KS patients, once thought to act alone, are now
recognized as cooperating mutations, and the prevalent notion
states that most KS/nCHH cases should be a bi-genic or oligo-
genic disease (21, 22). This raises hopes that a more exhaustive
knowledge of cooperating genes and mutations, should consent a
better prognosis and possibly personalized therapies.
Methods and algorithms have been proposed to iden-
tify/prioritize novel disease genes, based on (meta)-analyses of
specific profiling data, co-expression networks, genome locations,
functional categorizations, protein-protein interactions, etc. (90,
94). These methods have several advantages over direct whole
exome sequencing of large panels of DNAs from KS/nCHH
patients (95–97). In this study, on one side we have uncov-
ered functional classes, possible networks, and individual genes
involved in the olfactory/GnRH developmental, and validated
some of them in the zebrafish model recapitulating the KS pheno-
type. On the other side we positioned known human genes causing
KS and mouse models with a KS-like phenotype in gene-co-
expression networks, in order to identify genes potentially relevant
for the process and candidate KS-disease genes.
Embryonic development of the olfactory connection and the
migration of immature GnRH neurons are anatomically and func-
tionally linked. Since olfactory detection is a primary sensory
system in most vertebrates, and sexual maturation/reproduction
is essential for the species, it is not surprising the developmental
process is highly conserved and is controlled by multiple – partially
redundant – networks of molecular regulations. The high degree
of conservation among vertebrates justifies the use of the zebrafish
embryo for in vivo testing (98): not only its general anatomy has
not greatly changed, but also the migration of GnRH neurons
along the terminal nerve, in association with the VNO axons has
been overall maintained (83).
We have generated profiling data, comparing the mouse normal
OE and VNO at three developmental time-points, and comparing
the normal vs. a mutant model characterized by a KS-like pheno-
type. The data have been used to identify novel gene categories
involved in the development of the olfactory system, to identify
Dlx5 target genes in the OE, and to intersect this wealth of infor-
mation with data from other sources. As a further step, it might be
useful to generate profiles from other models of KS in the mouse
(i.e., Prok2, Fezf1, etc.) and intersect the results searching for com-
mon patterns and co-regulations. We have attempted this, however
with little success, most likely because we specifically profiled the
olfactory epithelia, while data form the Emx2 and Klf7 models
were generated from the OB. Likewise, it would be useful to inter-
sect our profiles from the Dlx5 model with datasets from freshly
dissociated embryonic GnRH neurons.
Categories that emerge from the “time course” profiles strongly
implicate extracellular matrix remodeling, cell adhesion, and cell–
cell signaling molecules. This is true both for the OE and VNO
development, that after all appear more “similar” than “different.”
The profiles of the“pathologic” condition, i.e., the Dlx5 knock-out
model, indentified a number specific molecules in the categories
of membrane receptors/adhesion molecules, axon-glia interaction
molecules, but nothing specifically related to “axon elongation.”
This suggests that the cell-autonomous properties of the olfac-
tory/VNO axons to establish connections, provided (directly or
indirectly) by the transcription factor Dlx5, reflects cytoskeletal
properties and cell surface events, mediated by receptors, scaffold
proteins and cell adhesion (see below).
Since profile data may easily lead to false positives, functional
validations are mandatory; we show that the zebrafish embryo
can be effectively used either to examine the trajectory and of the
olfactory axons, or the status of the GnRH3 neurons. We have
functionally tested five genes for olfactory axons, and three genes
for GnRH3 neurons, and the results clearly indicate that the chosen
genes do affect axonal trajectory and GnRH3 migration. Previous
works have shown that the depletion of z-kal1a/kal1b in the fish
embryo also causes KS-like phenotypes (45, 46), thus the use of
the reporter zebrafish strains we have adopted appears to be a valid
approach in which to examine new KS-causing genes in human,
or genes causing a KS-like phenotype when mutated in mice.
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Work is continuing in this direction. The following interesting
genes/categories emerge from the profile data.
THE LEUCINE-RICH REPEAT PROTEINS
We identified three leucine-rich repeat transmembrane protein
genes among the Dlx5−/− targets, namely Lrrn1, Lingo2, and Lgi1.
We functionally tested two of these using zebrafish embryos, and
the results clearly show that these proteins participate in the
development of the olfactory pathway. Lrrn1 was also tested in
GnRH3:GFP fish embryos, and the results show that it is required
for correct GnRH neuron migration. Furthermore, Lingo1, Lingo2,
and Lgi were prioritized with the human network, and Lrrtm
(another member of this family) emerged from the mouse
network.
Lrrn1 is a glycosylated single-pass transmembrane protein
with 12 external leucine-rich repeats, a fibronectin domain, an
immunoglobulin domain and short intracellular tails capable of
mediating protein-protein interaction. Lrrn1 is closely related
to drosophila tartan/capricious (trn/caps) proteins. Differential
expression of trn/caps promotes an affinity difference and bound-
ary formation between adjacent compartments in a number of
contexts. The regulated embryonic expression and cellular location
of these proteins suggest important roles during mouse develop-
ment in the control of cell adhesion, movement, or signaling (99).
Indeed, Lrrn1 has been identified as a positive and negative regula-
tor of neurite growth (100). Lrrn1 appears to be a key regulator of
the process of generating distinct cells at the midbrain-hindbrain
boundary of the brain. In the chick embryo Lrrn1 is dynami-
cally expressed, the timing of its down-regulation correlates closely
with the activation of signaling molecule expression at bound-
ary regions. Cells over-expressing Lrrn1 violate the boundary and
this result in a loss of cell restriction at the midbrain-hindbrain
boundary (101). Lrrn1 may regulate the subcellular localization of
specific components of signaling or cell–cell recognition pathways
in neuroepithelial cells (102).
Lingo2 is an exclusively neuronal transmembrane pro-
tein (103), containing 12 extracellular leucine-rich repeats, an
immunoglobulin C2 domain and a short intracellular tail, and
with a predicted structure similar to the Trk Receptor Tyrosine
Kinases. In human Lingo2 been linked both to essential tremor
and to Parkinson’s disease (104). Interestingly, the combination of
leucine-rich repeat and immunoglobulin-like domains is found in
the domain architecture of the Trk neurotrophin receptor protein.
In the mouse embryo Lingo2 is expressed in a the olfactory neurep-
ithelium and in various areas of the adult brain (99). Lingo1,
another neuron-specific member of the same family, has been
shown to be a component of the Nogo66 receptor/p75 signal-
ing complex (74). This ternary complex confers responsiveness to
oligodendrocyte myelin glycoprotein, as measured by RhoA acti-
vation. Such responsiveness is linked to the inhibition of axon
regeneration of neurons in the adult brain, by myelin. Thus,
Lingo proteins are likely to play a role in neurite outgrowth and
oligodendrocyte differentiation.
Lgi1 is a leucine-rich repeat molecule, found to be down-
regulated in the absence of Dlx5. This is a secreted molecule
of the SLIT family, promotes formation of stress fibers, inhibits
cell movement and invasion, and enhances growth of neuronal
processes on myelin-based substrates (75, 76). At the moment we
have no functional data on the possible role of Lgi1 in olfactory
development, yet should be explored.
MULTI-ADAPTOR SCAFFOLD MOLECULES
Among the Dlx5 targets we note the presence of a set of scaffold-
adaptor proteins, including Akap6, Dapp1 (also known as BAM32),
and Homer2. Akap6 belongs to a class of protein kinase A-
anchoring proteins, serving as scaffolds to cluster PKA and PDE
and to coordinate the timing/intracellular localization of cAMP
signaling. Akap proteins also bind to- and modulate-signaling
through ERK, MAPK, and PP2A (105, 106). The potential impor-
tance of this class of molecules is suggested by the fact that Akap6
(expressed in olfactory neurons) and Akap2 (expressed in the mes-
enchyme) emerge as predicted/prioritized disease genes from the
human network. Akap6 is absent in the zebrafish genome and
could not be tested.
Dapp1 codes for a signaling adapter molecule, much studied
in B lymphocyte activation, in which it coordinates timing and
location of signaling by PIP3 and PIP2 with that of ERK. Dapp1
also binds F-actin and Rac (107–109). Dapp1 is not apparently
expressed in the embryonic OE, nevertheless when Dapp1 was
depleted in the fish model a mild effect on axonal trajectory and
OPL organization have been observed. It appears very likely that
lipid signaling is involved in axonal trajectory and connectivity
during olfactory development.
Homer2 is a post-synaptic scaffold molecule, involved in recep-
tor clustering and modulating their downstream signaling. How-
ever, recently a role for Homer2 in tuning the activity of G-
proteins coupled receptors (such as the ORs) by controlling cal-
cium influxes has been demonstrated. We carried out functional
experiments depleting Homer2 in zebrafish embryos: the results
provide evidence for its involvement in olfactory axonal devel-
opment. Considering the established importance of the OR for
olfactory axon connectivity and guidance during embryonic devel-
opment, much before their role in odor perception, an embryonic
role of Homer2 can be envisioned, and our results with zebrafish
clearly show this.
The p130CAS – Shep1 regulation
Mouse embryos null for Shep1 show retarded OE differentiation,
lack of primary axonal connections with the OB and retention of
GnRH neurons in the nasal mesenchyme (110). These defects are
accompanied by a reduced phosphorylation of the multi-adapter
scaffold molecule p130CAS in the olfactory neurons and axons.
Shep1 promotes Src-dependent phosphorylation of the multi-
adapter molecule p130CAS, in vitro (111). These data implicate
the phosphorylation of p130CAS in the establishment of olfactory
contacts and in GnRH neuron migration, in line with previous
studies suggesting that p130CAS is required for neurite outgrowth
and axon guidance (112–114). p130CAS belongs to a family of
multi-adaptor and scaffold molecules that spatially and tempo-
rally collect, integrate, and modulate signals coming from RTKs
and adhesion receptors (115–117), undergoing changes in phos-
phorylation and interacting with a large set of effectors proteins.
In light of the phenotype of Shep1−/− mice, the involvement of
p130CAS in olfactory development and GnRH neuron migration
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is a likely possibility to be explored. Since p130CAS null mice
are embryonic lethal (118), this study will have to be pursued via
conditional deletion of p130CAS in the olfactory system.
St8siaVI codes for a sialyl-transferase, expressed by olfactory
neurons. The highly related St8siaII and St8siaIV proteins are
required for polysialylation the N-CAM, confer to this neuronal
surface molecule anti-adhesive properties and thereby promote
neurite elongation and cell migration (77–79). Thus a role for this
protein in OE development is conceivable, and supported by the
presented data in fish embryos.
EphA3 codes for a receptor for the guidance molecules Eph-
rinA3 and EphrinA5, which are expressed by VNO axons and have
a preference for interacting with EphA expressing cells in the Acces-
sory OB. Alterations of this pathway leads to abnormal topography,
i.e., guidance defects, of the olfactory and VNO axons (119), indi-
cating the EphrinA-EphA system is a positive guidance cue. Dlx5
is co-expressed with EphrinA3 and EphrinA5 in the VNO, while
EphA3 is expressed in the mesenchyme near the VNO (Figure S7
in Supplementary Material). The link between Dlx5 and EphA
signaling should be deeply explored.
GENES EMERGING FROM THE BIOINFORMATIC ANALYSES
A recent work has succeeded to use bioinformatics to priori-
tize candidate KS genes, focusing on the FGF8 co-expression and
functional network (7). Inspired by this work, we opted for an un-
biased approach that simultaneously searches for links between
genes apparently unrelated. Limiting our search to co-regulations,
we strongly introduce the notion of conservation, reasoning that
the olfactory/GnRH development is highly conserved within ver-
tebrates. Indeed, in our work we have attempted to use also mouse
KS-disease genes to run the search. The advantage is the pos-
sibility to use all the disease genes, instead of focusing only on
those logically related. An additional advantage of the present
work derives from combining bioinformatic predictions, putative
gene functions, phenotype descriptions, and information from
the literature with “wet” profiling data specifically obtained from
embryonic olfactory tissues.
The “human” network was able to predict few mouse KS gene
(Ebf2 and Nrp1), providing an evidence that the algorithm is effec-
tive. The outcome, both in terms of individual genes and the G.O.
classes, assures that the pipeline works. The addition of protein-
protein interaction data (when made available) or other data to
carry out meta-analyses will certainly refine the results. On the
contrary, it appears that the “mouse” gene network is little infor-
mative, i.e., less able to predict the human KS genes. This might
be due to the fact that the definition of mouse input gene is based
on accurate phenotypic analyses on the olfactory system, reported
in the literature, that scientist don’t routinely conduct (we may
miss many other genes) or it is incomplete and does not examine
olfactory axons but only hypothalamic GnRH neurons.
The predicted/prioritized genes emerging from our analyses
may represent a novel set of KS-causing genes, or genes that might
contribute when co-mutated with others. While the use of modern
sequencing approach (WES) on KS patients’ DNAs is the straight-
forward approach to define their role in the human disease, addi-
tional filters may be needed to further prioritize these genes, i.e.,
testing their function on GnRH3+ neurons fish embryos.
TRIM2 – tripartite motif containing 2, codes for an E3 ubiquitin-
protein ligase that has been implicated in ubiquitination of neu-
rofilament light chains. TRIM2 controls the dynamic of neu-
ronal cytoskeleton, by which determines the specification of the
choice of the axonal vs. dendritic projection in hippocampal
neurons (120).
CDH2 – cadherin-2, also known as N-cadherin, codes for a
well known calcium-dependent neuronal cell adhesion molecule
that contributes to the formation of neural circuits by regulating
growth cone migration and synapse formation. In the mam-
malian embryonic neocortex, radial migration is instructed by
several signals that include homophilic interactions mediated by
Cdh2 (121), and the fish embryo Cdh2 is involved in neurob-
last migration within the hindbrain (122, 123). Chd2 function
is required for guidance of afferent fibers of cranial sensory
neurons (124) and regulates motor axon growth and branch-
ing, in fish embryos (125). During olfactory development, Cdh2
is expressed by receptor neurons and closely parallels expres-
sion of γ-catenin in neuronal axons (126), thus Cdh2 is posi-
tioned to underlie the formation of olfactory primary olfactory
connections.
ADAMTS5 codes for a disintegrin-like and metallopeptidase
extracellular protease, with thrombospondin-like motif. Adamts5
plays a role in the specification and patterning of progenitor cells
in the lateral and medial ganglionic eminences (127). The pro-
teolytic cleavage of astrocyte-derived proteoglycan, exerted by
Adamts5, loosens the matrix environment and promotes neu-
rite outgrowth (128). Being predicted by both the human and
the mouse disease-gene networks, Adamts5 appears to be a very
interesting candidate.
RGS5 – regulator of G-protein signaling 5, codes for a protein that
accelerates the inactivation of Gα-dependent signaling in various
cells types. Down-regulation of RGS5 induces GPCR-mediated
signaling pathways and promotes migration of vascular and cancer
cells (129, 130). A role of this protein in promoting the migration
of GnRH neurons is possible, although RGS5 null mice don’t show
any obvious phenotype (131).
DPF3 – D4, zinc and double PHD fingers, family 3, codes for a
component of the BAF chromatin remodeling protein, and acts a
transcription co-activator in SWI/SNF complex-activation (132).
DPF3 functions to activate transcription of the target genes Pitx2
and Jmjd1c in association with the BAF complex, and binds histone
H3 and H4 in an acetylation-dependent manner (133, 134). How
this could be relevant for olfactory development, GnRH neuron
migration and KS, is unclear.
FGF7 has been proposed to act as a pre-synaptic organiz-
ing molecule in the mammalian brain, and in particular dur-
ing hippocampal development. Indeed FGF7-deficiency impairs
inhibitory synapse formation, which results in mossy fiber sprout-
ing and enhanced neurogenesis (91, 92). Neutralization of FGF7
inhibits pre-synaptic differentiation of mossy fibers at contact with
granule cells, and inactivation of FGFR2 has similar effects (92).
In neurons, FGFs and cell adhesion molecules stimulate neurite
outgrowth via activation of FGF receptors. A role for FGF7 for
the migration of enteric neuroblasts has been suggested from
analyses of CAMs and FGFs expression in Hirschsprung Disease
patients (93).
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CONCLUSION
The molecular control over the ability of olfactory axons to con-
tact the anterior forebrain, and/or the ability of GnRH neurons to
efficiently migrate and home to the hypothalamus, entails numer-
ous proteins of various functional classes, many of which appear
to be directly and indirectly involved in matrix remodeling and
signaling. Indeed, the data indicate that the navigation of OE and
VNO axons is mostly governed by cell–cell and cell-matrix cues,
rather than intrinsic properties of the axons. These include a set
of scaffold molecules that, for their nature, are strong candidates
for playing a key role in guiding axonal elongation-guidance and
connectivity, as well as for GnRH neuron migration and hom-
ing. These molecules will be of great interest for developmental
biologists.
Perturbations in the expression and sequence (mutations) of
these molecules and in their associated gene networks may cause
phenotypes similar to KS, a possibility that can be rapidly tested
in zebrafish strains, and eventually in the mouse. Human geneti-
cists should consider these molecules for mutation screens. This
opens the possibility to test them in the mammalian model and to
search for mutations in large collections of DNAs from KS/nCHH
patients, hereditary, or sporadic, with the hope to find mutations,
alone or in combination with mutations in known KS/nCHH
genes.
Finally we show the validity of approaches based on high-
throughput data generation and predictive bioinformatics to iden-
tify genes potentially relevant for specific developmental processes,
and ultimately for disease. Indeed, we have uncover a set of mole-
cules that might be candidate disease genes, to be tested in future
mutation screens.
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